- In Q4 2025, Darling Ingredients reported total sales of US$1.70 billion, up from US$1.40 billion a year earlier, alongside upbeat commentary on its renewable fuels and core ingredient operations, which together have drawn fresh attention from investors.
- At the same time, the company’s move to combine its collagen and gelatin units into a joint venture with Tessenderlo highlights how management is refocusing the portfolio toward higher-value food ingredients and health-related applications.
- We’ll now examine how the collagen and gelatin joint venture, alongside improving margins, may influence Darling Ingredients’ broader investment narrative.
The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
Darling Ingredients Investment Narrative Recap
To own Darling Ingredients, you need to believe in its role turning waste into higher value ingredients and renewable fuels, while managing significant policy and margin uncertainty. The latest Q4 2025 beat and stronger sentiment around renewable fuels appear supportive of the near term earnings recovery story, but do not remove key risks around renewable diesel utilization, volatile feedstock costs, and a still-elevated leverage profile, which together remain central to the stock’s near term catalyst and downside risk.
The recently announced collagen and gelatin joint venture with Tessenderlo is the clearest link between this quarter’s attention on renewable fuels and the longer term push into health oriented food ingredients. As this JV takes shape, investors will be watching how it affects mix, margins, and capital needs alongside any improvement in renewable diesel profitability, since execution across both areas could influence how quickly Darling reduces balance sheet risk and broadens its earnings base.
Yet even with stronger recent results, investors should still be alert to how policy shifts around renewable fuels could suddenly reshape margins and...
Read the full narrative on Darling Ingredients (it's free!)
Darling Ingredients' narrative projects $6.5 billion revenue and $673.1 million earnings by 2028. This requires 4.3% yearly revenue growth and about a $567.7 million earnings increase from $105.4 million today.
Uncover how Darling Ingredients' forecasts yield a $47.46 fair value, a 13% downside to its current price.
Exploring Other Perspectives
Some of the most cautious analysts were assuming only about 3.5 percent annual revenue growth and earnings of roughly US$520 million by 2028, reminding you that regulatory and execution risks can look very different depending on your assumptions and that it is worth comparing this more pessimistic view with the impact of recent results before deciding which story you find more convincing.
Explore 3 other fair value estimates on Darling Ingredients - why the stock might be worth 13% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Darling Ingredients research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
- Our free Darling Ingredients research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Darling Ingredients' overall financial health at a glance.
No Opportunity In Darling Ingredients?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
- Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com